Timothy V. Williams, SVP & General Counsel at Vanda Pharmaceuticals Inc. (VNDA), sold 24,120 shares at $11.09 ($267K) on 2022-03-02, disclosed to the SEC on 2022-03-02.
Seasonal sale ($267k) by SVP & General Counsel — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.09 | 12,060 | $134K | 50.0% |
| 2 | $11.09 | 12,060 | $134K | 50.0% |
| Total | $11.09 avg | 24,120 | $267K | 100% |
| Filing → |
| VNDA | SELL | 2024-03-06 | $73K | — | Filing → |
| VNDA | SELL | 2023-06-15 | $96K | — | Filing → |
| PRO | SELL | 2023-05-15 | $151K | — | Filing → |